If a patient's postprandial glucose is 300 mg/dL, how many units of rapid‑acting insulin (e.g., insulin lispro, insulin aspart, or regular insulin) should be administered?

Correction Insulin Dosing for Postprandial Glucose of 300 mg/dL

Direct Recommendation

For a postprandial glucose of 300 mg/dL, administer correction insulin using rapid-acting insulin (lispro, aspart) or regular insulin based on an individualized correction factor, typically starting with 1 unit of insulin per 50 mg/dL above target (1:50 rule) or 1 unit per 30 mg/dL above target (1:30 rule) depending on insulin sensitivity. 1

Clinical Context and Severity Classification

• A postprandial glucose of 300 mg/dL (16.6 mmol/L) represents severe hyperglycemia in the non-critically ill hospitalized patient 1
• This level requires immediate correction with rapid-acting or short-acting insulin 1
• The correction dose must account for the patient's insulin sensitivity, current insulin regimen, and whether this represents an isolated spike or persistent hyperglycemia 2

Calculating the Correction Dose

Step 1: Determine Target Glucose

• Use a target glucose of 100–130 mg/dL for most patients 1
• For this calculation: 300 mg/dL – 130 mg/dL = 170 mg/dL above target

Step 2: Apply Correction Factor (Insulin Sensitivity Factor)

Standard correction factors:

• 1:50 rule: 1 unit of rapid-acting insulin lowers glucose by ~50 mg/dL (less insulin-sensitive patients) 1
• 1:30 rule: 1 unit lowers glucose by ~30 mg/dL (more insulin-sensitive patients) 1

For a glucose of 300 mg/dL:

• Using 1:50 rule: 170 mg/dL ÷ 50 = 3–4 units of rapid-acting insulin 1
• Using 1:30 rule: 170 mg/dL ÷ 30 = 5–6 units of rapid-acting insulin 1

Step 3: Adjust Based on Patient Factors

Give the lower dose (3–4 units) if the patient:

• Is insulin-naive or on low-dose insulin at home (<0.3 U/kg/day) 1
• Has a history of hypoglycemia 1
• Has reduced oral intake 1
• Has renal or hepatic impairment 2

Give the higher dose (5–6 units) if the patient:

• Is on high-dose insulin at home (>0.6 U/kg/day) 1
• Has persistent hyperglycemia despite previous corrections 1
• Has steroid-induced hyperglycemia 1

Insulin Selection and Timing

Rapid-Acting Insulin Analogues (Preferred)

• Insulin lispro or aspart are the preferred agents for correction doses 2, 3
• Administer within 5–10 minutes before or immediately after verifying the glucose level 2
• Onset of action: 10–15 minutes; peak effect: 1–2 hours; duration: 3–5 hours 2, 3
• These analogues lower postprandial glucose more effectively than regular insulin, with a 22.2 mg/dL greater reduction in type 1 diabetes 3

Regular Human Insulin (Alternative)

• Use if rapid-acting analogues are unavailable 4
• Administer 30 minutes before the next meal or snack 4
• Onset: 30 minutes (range 10–75 minutes); peak: 3 hours; duration: 8 hours 4
• The longer duration increases late hypoglycemia risk compared to rapid-acting analogues 3

Administration Route

• Subcutaneous injection into the abdomen, thigh, buttocks, or upper arm 2
• Rotate injection sites to prevent lipodystrophy 2
• Do not mix rapid-acting insulin with any insulin except NPH if using a mixed regimen 2

Monitoring and Follow-Up

• Recheck glucose in 2 hours after administering rapid-acting insulin 1, 2
• If glucose remains >200 mg/dL after 2 hours, give an additional correction dose using the same calculation 1
• Avoid stacking corrections within 3–4 hours to prevent cumulative hypoglycemia 1

Common Pitfalls and How to Avoid Them

Pitfall 1: Under-Dosing in Insulin-Resistant Patients

• Patients on high-dose insulin at home (>0.6 U/kg/day) or with steroid-induced hyperglycemia require more aggressive correction (use 1:30 rule or higher) 1
• A single 3–4 unit dose will be insufficient in these patients 1

Pitfall 2: Over-Dosing in Insulin-Sensitive Patients

• Insulin-naive patients or those with low HbA1c (<7%) are at high risk for hypoglycemia 1
• Start with the 1:50 rule and monitor closely 1

Pitfall 3: Ignoring Insulin-on-Board

• If the patient received prandial insulin <3 hours ago, reduce the correction dose by 50% or wait until the previous dose has peaked 1
• Rapid-acting insulin duration is 3–5 hours; stacking doses increases hypoglycemia risk 2

Pitfall 4: Using Correction Doses Alone for Persistent Hyperglycemia

• If postprandial glucose is consistently >300 mg/dL, correction doses are insufficient 1
• Transition to a basal-bolus regimen with scheduled prandial insulin (0.3 U/kg/day total daily dose, split 50% basal and 50% bolus) 1
• For patients already on basal-bolus therapy, increase the prandial insulin dose by 10–20% at the meal preceding the high glucose 1, 5

Pitfall 5: Delaying Treatment

• Severe hyperglycemia (>300 mg/dL) is associated with poor hospital outcomes and requires immediate correction 1
• Do not wait for the next scheduled insulin dose; administer correction insulin as soon as the elevated glucose is confirmed 1

When to Escalate Therapy

If glucose remains >300 mg/dL despite correction doses:

• Initiate or intensify a basal-bolus insulin regimen 1
• Start with 0.3–0.5 U/kg/day total daily dose (50% basal, 50% bolus divided before meals) 1
• For patients already on insulin at home, reduce their home total daily dose by 20% and split it as above 1

If the patient is critically ill or has diabetic ketoacidosis:

• Transition to continuous intravenous insulin infusion under close monitoring 1

Special Considerations

• Type 1 diabetes: These patients require continuous insulin coverage; never withhold basal insulin even if NPO 1
• Steroid-induced hyperglycemia: Expect higher insulin requirements; use more aggressive correction factors 1
• Renal or hepatic impairment: Insulin clearance is reduced; start with lower correction doses and monitor closely 2